$APRE ISIN: US03836J2015 Forum: Aktien User: 00000

Aprea Therapeutics (Nasdaq: APRE) announced a private placement to sell 2,623,023 shares (or pre-funded warrants) plus warrants to purchase up to 2,623,023 shares, priced at-the-market under Nasdaq rules. The combined effective offering price per share (or pre-funded warrant) with accompanying warrant is $1.165, producing estimated gross proceeds of approximately $3.1 million before placement agent fees and expenses. Warrants carry a $1.04 exercise price, are exercisable immediately, and expire on the five-year anniversary tied to registration/resale eligibility. The company said net proceeds are intended for general corporate purposes and R&D and are expected to extend cash runway into Q1 2027. The Offering is expected to close on or about December 10, 2025, with Maxim Group as sole placement agent.